en

PRODUCT DETAIL

Ebglyss 250 mg injekčný roztok v naplnenom pere

Code 5067E
MA number EU/1/23/1765/007
Product Form: sol inj 1x2 ml/250 mg (pero napl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Almirall, S.A., Spain
Therapeutic Class: 46 - DERMATOLOGICA
ATC:
D DERMATOLOGICALS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11AH Agents for dermatitis, excluding corticosteroids
D11AH10 Lebrikizumab
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 16.11.2023
Validity: 16.11.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 17.01.2024
eu-flag.png sk-flag.png